Pathstone Family Office’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$445K Buy
4,517
+1,872
+71% +$194K ﹤0.01% 1097
2023
Q2
$278K Buy
2,645
+611
+30% +$65K ﹤0.01% 988
2023
Q1
$206K Sell
2,034
-404
-17% -$40.3K ﹤0.01% 1082
2022
Q4
$239K Sell
2,438
-205
-8% -$18.9K ﹤0.01% 1318
2022
Q3
$213K Buy
+2,643
New +$232K ﹤0.01% 1324
2019
Q2
Sell
-54
Closed -$5K 759
2019
Q1
$5K Hold
54
﹤0.01% 593
2018
Q4
$5K Buy
+54
New +$5.4K ﹤0.01% 378
2018
Q2
Sell
-92
Closed -$12K 230
2018
Q1
$12K Buy
+92
New +$12.3K 0.01% 209

Other funds holding INGR

Pathstone Family Office's INGR Position: Q3 2023 in Review

Pathstone Family Office increased its Ingredion (INGR) stake by 71% in Q3 2023, buying an estimated $194K and bringing the position to 4,517 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #1097.

Pathstone Family Office first reported a position in INGR in Q1 2018 and has held it in 8 quarters since. 482 funds tracked by Wall St. Rank hold INGR as of Q3 2023.

  • Pathstone Family Office held 4,517 shares of Ingredion worth $445K as of Q3 2023.
  • Pathstone Family Office bought 1,872 Ingredion shares in Q3 2023, an estimated $194K.
  • Ingredion made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1097 holding.
  • Pathstone Family Office first reported a position in Ingredion in Q1 2018 and has held it in 8 quarters since.
  • 482 funds tracked by Wall St. Rank held Ingredion as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.